Photo of Enable Injections — HQ Renovation & Manufacturing Expansion

Enable Injections — HQ Renovation & Manufacturing Expansion

Overview

KMK Consulting (KMKC) was engaged by Enable Injections, Inc. (Enable), a global healthcare company, to assist with the establishment of a new manufacturing facility and expansion of its corporate headquarters. Enable is a global healthcare brand devoted to developing innovative drug delivery systems that improve patient experience, increase safety, and reduce the healthcare burden. Since its founding in 2010, Enable has devoted efforts to effectuating the concept of painless medical injections. Instead of spending hours per session attending hospitals and doctors' offices to receive painful rounds of injections, Enable strives to provide patients with a body-worn device capable of being administered by the patients themselves while going about their daily activities.

challenges

Enable's manufacturing capacity is critical to the goal of providing patients with painless injection alternatives. To pursue this objective, Enable developed an ambitious plan to renovate and expand its key facilities. Enable's construction of a 90,000-sq/ft Manufacturing Center of Excellence facility required effective collaboration between sophisticated state, regional, and local governments. As one of the fastest-growing healthcare brands in the nation, Enable required fast-paced and high-quality consulting services to make this significant expansion an optimal success. For a project of this size, Enable faced difficulty in balancing a plethora of competing interests, including multiple state jurisdictions and various levels of government. Achievement of these goals was further complicated by Enable's need to develop a strategy harmonizing its immediate and long-term costs.

outcomes

KMK Consulting managed the incentive analysis, review, and negotiations at various governmental levels and between multiple states, working to identify creative solutions to help offset the company's immediate and long-term costs. The KMKC team worked diligently through complex real estate incentives, leveraging existing financial tools to create new customized incentive solutions. Enable's renovation and expansion was able to create 450 jobs, retain 193 jobs, generate $19.8M in payroll and shepherd a total capital investment of $124M.

Stats

JOBS CREATED
257
JOBS RETAINED
193
created payroll
$19.8M
TOTAl investment
$124M

Hear From the Company

"Scalable, in-house manufacturing is a key pillar of Enable's strategy to accelerate supply of our innovative enFuse technology as the Company continues to grow our roster and scope of clinical and commercial engagements with pharmaceutical partners. This new facility allows Enable to significantly expand and enhance production processes and ultimately reduce the time it takes to bring our enFuse system to patients and the medical community."

Mike Hooven
CEO, Enable Injections, Inc.

Jump to Page
Close

The earlier you engage a professional incentives consultant, the better. Contact us today.

James J. McGraw, Jr.
President & CEO
513.639.3968
jmcgraw@kmkconsulting.com
Thomas G. Seward, Jr.
Managing Director
513.639.3970
tseward@kmklaw.com
Brandon E. Simmons
Managing Director
513.639.3971
bsimmons@kmklaw.com

Ian M. Smith
Director
513.579.6570
ismith@kmklaw.com

Necessary Cookies

Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.

Functional Cookies

Functional cookies collect information about your choices and preferences, and collect information about your use of the Sites and Services which enable us to improve functionality.

Analytical Cookies

Analytical cookies help us improve our website by collecting and reporting information on its usage. We access and process information from these cookies at an aggregate level.